Turn Therapeutics Inc. TTRX
8.55 USD -0.79 (-8.51%)
Regular-session close
8.55 0.00 0.00%
After hours · Nov 16, 4:00 PM ET
8.20 Day range 9.64
2.57 52-week range 16.45
- YTD
- +117.01%
- 1 year
- +113.75%
News
gurufocus.com Turn Therapeutics Provides Corporate Updates and Reports Third Quarter 2026 Financial Results Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing targeted, non-systemic therapies for inflammatory and infectious skin dbenzinga.com Turn Therapeutics Q3 EPS $(0.21) Misses $(0.09) Estimate Turn Therapeutics (NASDAQ:TTRX) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.09) by 162.5 percent. This is a 200 percent decrease over losses of…
businesswire.com Turn Therapeutics Provides Corporate Updates and Reports Third Quarter 2026 Financial Results WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing targeted, non-systemic therapies for inflammatory and infectious…
benzinga.com This Tesla Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday Analysts upgraded SAFE, CNOB, LMT and more.
benzinga.com This Allegion Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings…benzinga.com WBB Securities Upgrades Turn Therapeutics to Hold, Maintains Price Target to $10 WBB Securities analyst Karen Sterling upgrades Turn Therapeutics (NASDAQ:TTRX) from Sell to Hold and maintains the price target from $10 to $10.
